Doxorubicin Loaded Magnetic Polymersomes: Theranostic Nanocarriers for MR Imaging and Magneto-Chemotherapy

Charles Sanson,Odile Diou,Julie Thevenot,Emmanuel Ibarboure,Alain Soum,Annie Brûlet,Sylvain Miraux,Eric Thiaudière,Sisareuth Tan,Alain Brisson,Vincent Dupuis,Olivier Sandre,Sébastien Lecommandoux
DOI: https://doi.org/10.48550/arXiv.1209.5098
2012-09-23
Soft Condensed Matter
Abstract:Hydrophobically modified magnetic nanoparticles (MNPs) were encapsulated within the membrane of poly(trimethylene carbonate)-b-poly(L-glutamic acid) (PTMC-b-PGA) block copolymer vesicles using a nanoprecipitation process. This formulation method provides a high loading of MNPs (up to 70 wt %) together with a good control over the sizes of the vesicles (100 - 400 nm). The deformation of the vesicle membrane under an applied magnetic field was evidenced by anisotropic SANS. These hybrid objects display contrast enhancement properties in Magnetic Resonance Imaging, a diagnostic method routinely used for three-dimensional and non-invasive scans of the human body. They can also be guided in a magnetic field gradient. The feasibility of drug release triggered by magnetic induction was evidenced using the anticancer drug doxorubicin (DOX), which is co-encapsulated in the membrane. Magnetic polymersomes are thus proposed as multimodal drug nanocarriers for bio-imaging and magneto-chemotherapy.
What problem does this paper attempt to address?